Ann: Updated HeraMED Investor Update Conference Call, page-4

I liked it..

Overall very positive stuff, I think @geffa9 might have been asking a question about Brazil and India? Basically those other countries are on the back burner for now which I feel is the right course particularly with regards to cash burn.

The Mayo trial is pivotal. It is focused on demonstrating that the HeraBEAT is in fact the clear and overall leader in the field and does what the others cannot do. Results to start in a couple of months if not weeks..

eCare and Teleperinatal are aggressive business builders and we are piggy backing their growth. Paid Pilot for Teleperinatal hence the lower numbers.

good story and might be getting better..